| These highlights do not include all the information needed to use BEIZRAY safely and effectively. See full prescribing information for BEIZRAY. BEIZRAY (docetaxel) injection, for intravenous use Initial U.S. Approval: 1996 | Zydus Pharmaceuticals USA Inc. | Kindos Pharmaceuticals Co., Ltd. | Ningbo Shuangcheng Pharmaceutical Co., Ltd | Bio Products Laboratory Ltd. | 20251217 | 4 |
| These highlights do not include all the information needed to use KEDBUMIN ® safely and effectively. See full prescribing information for KEDBUMIN ® [Albumin (Human) U.S.P.] sterile, aqueous solution for single dose intravenous administration Initial U.S. Approval: June, 2011. | Kedrion S.p.A | 20250627 | 17 |
| These highlights do not include all the information needed to use ALBUTEIN 20% safely and effectively. See full prescribing information for ALBUTEIN 20%. ALBUTEIN 20% (albumin [human] U.S.P.) 20% solution Initial U.S. Approval: 1978 | GRIFOLS USA, LLC | Grifols Biologicals LLC | Grifols Therapeutics LLC | INSTITUTO GRIFOLS SA | 20250528 | 15 |
| These highlights do not include all the information needed to use ALBUTEIN 25% safely and effectively. See full prescribing information for ALBUTEIN 25%. ALBUTEIN 25% (albumin [human] U.S.P.) 25% solution Initial U.S. Approval: 1978 | GRIFOLS USA, LLC | Grifols Biologicals LLC | Grifols Therapeutics LLC | INSTITUTO GRIFOLS SA | 20250528 | 17 |
| These highlights do not include all the information needed to use ALBUTEIN 5% safely and effectively. See full prescribing information for ALBUTEIN 5%. ALBUTEIN 5% (albumin [human] U.S.P.) 5% solution Initial U.S. Approval: 1978 | GRIFOLS USA, LLC | Grifols Biologicals LLC | Grifols Therapeutics LLC | INSTITUTO GRIFOLS SA | 20250528 | 17 |
| These highlights do not include all the information needed to use ALBUTEIN FlexBag 20% safely and effectively. See full prescribing information for ALBUTEIN FlexBag 20%. ALBUTEIN FlexBag 20% (albumin [human] U.S.P.) 20% solution Initial U.S. Approval: 1978 | GRIFOLS USA, LLC | Grifols Biologicals LLC | 20250528 | 3 |
| These highlights do not include all the information needed to use ALBUTEIN FlexBag 25% safely and effectively. See full prescribing information for ALBUTEIN FlexBag 25%. ALBUTEIN FlexBag 25% (albumin [human] U.S.P.) 25% solution Initial U.S. Approval: 1978 | GRIFOLS USA, LLC | Grifols Biologicals LLC | 20250528 | 10 |
| These highlights do not include all the information needed to use ALBUTEIN FlexBag 5% safely and effectively. See full prescribing information for ALBUTEIN FlexBag 5%. ALBUTEIN FlexBag 5% (albumin [human] U.S.P.) 5% solution Initial U.S. Approval: 1978 | GRIFOLS USA, LLC | Grifols Biologicals LLC | 20250528 | 13 |
| Plasma Protein Fraction (Human) 5%, USP Plasmanate ® | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | 20250405 | 11 |
| These highlights do not include all the information needed to use Human Albumin Grifols 20% safely and effectively. See full prescribing information for Human Albumin Grifols 20%. Human Albumin Grifols 20% Albumin (Human) U.S.P. 20% solution Initial U.S. Approval: 1995 | GRIFOLS USA, LLC | Instituto Grifols, S.A. | GRIFOLS WORLDWIDE OPERATIONS LIMITED | 20250211 | 16 |
| These highlights do not include all the information needed to use ALBUMINEX ® 25% Albumin (human) - kjda safely and effectively. See full prescribing information for ALBUMINEX ® 25%. ALBUMINEX ® 25% (human albumin) solution for injection Initial U.S. Approval: [2018] | BPL | 20241231 | 8 |
| These highlights do not include all the information needed to use ALBUMINEX ® 5% Albumin (human) – kjda safely and effectively. See full prescribing information for ALBUMINEX ® 5%. ALBUMINEX ® 5% (human albumin) solution for injection. Initial U.S. Approval: [2018] | BPL | 20241231 | 8 |
| These highlights do not include all the information needed to use FLEXBUMIN ® 20% safely and effectively. See full prescribing information for FLEXBUMIN 20%. FLEXBUMIN ® 20% Albumin (Human), USP, 20% Solution, for intravenous use Initial U.S. Approval: 2005 | Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc. | 20241218 | 17 |
| These highlights do not include all the information needed to use FLEXBUMIN ® 25% safely and effectively. See full prescribing information for FLEXBUMIN 25%. FLEXBUMIN ® 25% Albumin (Human), USP, 25% Solution, for intravenous use Initial U.S. Approval: 2005 | Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc. | 20241218 | 17 |
| These highlights do not include all the information needed to use FLEXBUMIN ® 5% safely and effectively. See full prescribing information for FLEXBUMIN 5%. FLEXBUMIN ® 5% Albumin (Human), USP, 5% Solution, for intravenous use Initial U.S. Approval: 2005 | Takeda Pharmaceuticals America, Inc. | BAXALTA INCORPORATED | Baxalta US Inc. | 20241218 | 14 |
| ALBUKED | A-S Medication Solutions | 20240628 | 10 |
| Albumin (Human) 20%, USP Plasbumin ® -20 | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | 20221118 | 14 |
| Albumin (Human) 25%, USP Plasbumin ® -25 | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | 20221118 | 16 |
| Albumin (Human) 5%, USP Plasbumin ® -5 | GRIFOLS USA, LLC | GRIFOLS THERAPEUTICS LLC | 20221118 | 15 |
| Albumin (Human) 25% Solution ALBURX ® 25 | CSL Behring AG | CSL Behring LLC | CSL Behring (Australia) Pty Ltd | 20220804 | 11 |
| Albumin (Human) 5% Solution ALBURX ® 5 | CSL Behring AG | CSL Behring LLC | 20220804 | 10 |
| Albumin (Human) 20%, USP Albuked™ 20 | KEDRION BIOPHARMA, INC. | GRIFOLS THERAPEUTICS LLC | 20200801 | 7 |
| Albumin (Human) 25%, USP Albuked™ 25 | KEDRION BIOPHARMA, INC. | GRIFOLS THERAPEUTICS LLC | 20200801 | 7 |
| Albumin (Human) 5%, USP Albuked™ 5 | KEDRION BIOPHARMA, INC. | GRIFOLS THERAPEUTICS LLC | 20200801 | 7 |
| These highlights do not include all the information needed to use ALBUMIN (HUMAN) 20% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 20%. ALBUMIN (HUMAN) 20% for infusion, for intravenous use Initial U.S. Approval: 2006 | Octapharma USA Inc | 20200406 | 7 |
| These highlights do not include all the information needed to use ALBUMIN (HUMAN) 25% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 25%. ALBUMIN (HUMAN) 25% for infusion, for intravenous use Initial U.S. Approval: 2006 | Octapharma USA Inc | 20200406 | 6 |
| These highlights do not include all the information needed to use ALBUMIN (HUMAN) 5% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 5%. ALBUMIN (HUMAN) 5% for infusion, for intravenous use Initial U.S. Approval: 2006 | Octapharma USA Inc | 20200406 | 7 |
| Allergenic Extract | Antigen Laboratories, Inc. | 20091208 | 3 |
| These highlights do not include all the information needed to use ALBUMIN (HUMAN) 20% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 20%. ALBUMIN (HUMAN) 20% For intravenous use only 20% solution Initial U.S. Approval: 2006 | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 20080801 | 5 |
| These highlights do not include all the information needed to use ALBUMIN (HUMAN) 25% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 25%. ALBUMIN (HUMAN) 25% For intravenous use only 25% solution Initial U.S. Approval: 2006 | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 20080801 | 4 |
| These highlights do not include all the information needed to use ALBUMIN (HUMAN) 5% safely and effectively. See full prescribing information for ALBUMIN (HUMAN) 5%. ALBUMIN (HUMAN) 5% For intravenous use only 5% solution Initial U.S. Approval: 2006 | Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. | 20080801 | 4 |